DaShenLin Pharmaceutical Group Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 11,141.165 million compared to CNY 8,859.273 million a year ago. Operating income was CNY 918.256 million compared to CNY 718.298 million a year ago. Net income was CNY 702.661 million compared to CNY 531.633 million a year ago. Basic earnings per share from continuing operations was CNY 1.34 compared to CNY 1.02 a year ago. Diluted earnings per share from continuing operations was CNY 1.26 compared to CNY 1.02 a year ago.